drugset / Trial / NCT06704698

Postoperative Analgesia Between Paravertebral Block and Epidural Block in Esophageal Surgery

NCT06704698 ↗

Recruiting 132 enrolled Zhejiang Cancer Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

Prevention of postoperative pain is essential for the recovery of esophageal surgery. Epidural analgesia is a traditional and standard perioperative pain management for these patients. Beneficials of epidural analgesia have been widely established. However, there are still several potential disadvantages such as perioperative hypotension, failure of administration, rare but serious neurological complications. Ultrasound-guided regional nerve block has become a widely used technique due to its low degree of trauma and precise target of action. In combined with liposome bupivacaine (LB), a new long-acting local anesthetic, was proven to have a maximum duration of 72 hours, thus improving postoperative analgesia, reducing opioid consumption, and enhancing patient satisfaction. The aim of this study was to evaluate the efficacy of TPVB liposomal bupivacaine (LB) or plane bupivacaine (SB) for Overall Benefit of Analgesic Score (OBAS) after esophageal surgery.

Timeline

Start
2024-12-03
Primary completion
2025-12-25
Completion
2025-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 0.25 % Other
Subject Bupivacaine Other / unclassified 66.5 mg Other
Subject Bupivacaine Other / unclassified 300 mg Other